Product Images Corlanor
View Photos of Packaging, Labels & Appearance
- Figure 1. Chemical Structure of Ivabradine - corlanor 01
- Figure 2. Impact of Coadministered Drugs on the Pharmacokinetics of Corlanor - corlanor 02
- Figure 3. SHIFT: Time to First Event of Primary Composite Endpoint - corlanor 03
- Figure 4. Effect of Treatment on Primary Composite Endpoint in Subgroups - corlanor 04
- NDC 55513-800-80AMGEN®Corlanor ®(ivabradine) tablets5 mgEach tablet contains 5 mg ivabradine equivalent to 5.39 mg ivabradine as hydrochloride.Oral Use.Store at 25°C, excursions permitted to 15°C - 30°C.Keep out of the sight and reach of children.Rx Only180 Film-coated tabletsManufactured for Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799Made in France - corlanor 05
- NDC 55513-810-80AMGEN®Corlanor ®(ivabradine) tablets7.5 mgEach tablet contains 7.5 mg ivabradine equivalent to 8.085 mg ivabradine as hydrochloride.Oral Use.Store at 25°C, excursions permitted to 15°C - 30°C.Keep out of the sight and reach of children.Rx Only180 Film-coated tabletsManufactured for Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799Made in France - corlanor 06
- corlanor 07
- corlanor 08
- corlanor 09
- corlanor 0a
- corlanor 0b
- corlanor 0c
- corlanor 0d
- corlanor 0e
- corlanor 0f
- corlanor 10
- corlanor 11
- corlanor 12
- corlanor 13
- corlanor 14
- corlanor 15
Product Label Images
The following 21 images provide visual information about the product associated with Corlanor NDC 55513-813 by Amgen Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1. Chemical Structure of Ivabradine - corlanor 01
Figure 2. Impact of Coadministered Drugs on the Pharmacokinetics of Corlanor - corlanor 02
This text seems to be a list of medications and their recommended usage in the presence of other medication or substances. It includes information on strong and moderate inhibitors, inducers, and other medications, as well as PK measures and recommendations for dosage adjustments. Some medications are listed as contraindicated, and others are recommended to be avoided or to have no dose adjustment.*
Figure 3. SHIFT: Time to First Event of Primary Composite Endpoint - corlanor 03
This appears to be a table with data related to heart failure (HF), but it is not clear what the variables mean. Therefore, it is not possible to generate a useful description.*
Figure 4. Effect of Treatment on Primary Composite Endpoint in Subgroups - corlanor 04
NDC 55513-800-80AMGEN®Corlanor ®(ivabradine) tablets5 mgEach tablet contains 5 mg ivabradine equivalent to 5.39 mg ivabradine as hydrochloride.Oral Use.Store at 25°C, excursions permitted to 15°C - 30°C.Keep out of the sight and reach of children.Rx Only180 Film-coated tabletsManufactured for Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799Made in France - corlanor 05
NDC 55513-810-80AMGEN®Corlanor ®(ivabradine) tablets7.5 mgEach tablet contains 7.5 mg ivabradine equivalent to 8.085 mg ivabradine as hydrochloride.Oral Use.Store at 25°C, excursions permitted to 15°C - 30°C.Keep out of the sight and reach of children.Rx Only180 Film-coated tabletsManufactured for Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799Made in France - corlanor 06
This text is describing the different parts of a syringe, including the markings on the syringe, the plunger stopper, and the plunger itself.*
corlanor 07
corlanor 08
The text suggests that the volume of an ampule is 5m. However, it is not clear if this represents a specific unit of measurement (e.g., milliliters, microliters, etc.) or if there is additional context missing. Therefore, it is recommended to seek further information or clarification to fully understand the meaning of the text.*
corlanor 09
Cortanar is a medication in ampule form with a volume of 5mL.*
corlanor 0a
corlanor 0b
corlanor 0c
corlanor 0d
corlanor 0e
corlanor 0f
corlanor 10
corlanor 11
corlanor 12
corlanor 13
The text is a product description for Corlanor - a medication produced by Amgen Inc. Each tablet contains 5 mg of ivabradine hydrochloride and is for oral use. It is advised to be stored at room temperature and kept out of reach of children. The enclosed medication guide should be dispensed to each patient. The text includes information on the recommended dosage, patent information, and copyright statement.*
corlanor 14
This is a medication description for Amgen's Corlanor tablets. Each tablet contains 7.5 mg of ivabradine (equivalent to 108.085 mg of wabradine as hydrochloride) for oral use. It is recommended to be stored at 25°C and kept out of sight and reach of children. The enclosed Medication Guide is to be dispensed to each patient. The recommended dosage is provided in the prescribing information.*
corlanor 15
This is a medication called Corlanor, with the active ingredient vabradine in 5mg/5mL oral solution form. It should be dispensed with both a medicine cup and sterile oral solution. It needs to be stored at a temperature between 15°C to 30°C and protected from light by storing it in a foil pouch. A medication guide needs to be dispensed to each patient.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
